We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
- Authors
GILL, J. C.; SHAPIRO, A.; VALENTINO, L. A.; BERNSTEIN, J.; FRIEDMAN, C.; NICHOLS, W. L.; MANCO-JOHNSON, M.
- Abstract
Summary. von Willebrand disease (VWD) is the most common inherited bleeding disorder. Treatment guidelines recommend the use of von Willebrand factor/factor VIII (VWF/FVIII) concentrate for VWD patients with type 2 or 3 VWD undergoing surgery, and type 1 patients undergoing surgery who are unresponsive, or for whom desmopressin acetate is contraindicated. This prospective, open-label, multinational study evaluated the safety, efficacy and optimal dosing of a VWF/FVIII concentrate (Humate-P) in subjects with VWD undergoing elective surgery. Dosing was based on VWF ristocetin cofactor (VWF:RCo) and FVIII pharmacokinetic assessments performed before surgery. Pharmacokinetic assessments were completed in 33 adults and 9 children. Haemostatic efficacy was assessed on a 4-point scale (excellent, good, moderate/poor or none). Overall effective haemostasis was achieved in 32/35 subjects. Median terminal VWF:RCo half-life was 11.7 h, and median incremental in vivo recovery was 2.4 IU dL−1 per IU kg−1 infused. Major haemorrhage occurred after surgery in 3/35 cases despite achieving target VWF and FVIII levels. Median VWF/FVIII concentrate loading doses ranged from 42.6 IU VWF:RCo kg−1 (oral surgery) to 61.2 IU VWF:RCo kg−1 (major surgery), with a median of 10 (range, 2-55) doses administered per subject. Adverse events considered possibly treatment-related ( n = 6) were generally mild and of short duration. The results indicate that this VWF/FVIII concentrate is safe and effective in the prevention of excessive bleeding during and after surgery in individuals with VWD.
- Subjects
VON Willebrand disease; ELECTIVE surgery; DESMOPRESSIN; RISTOCETIN; HEMOSTASIS
- Publication
Haemophilia, 2011, Vol 17, Issue 6, p895
- ISSN
1351-8216
- Publication type
Article
- DOI
10.1111/j.1365-2516.2011.02534.x